Targeted cellular immunotherapy for T cell malignancies
Nature Medicine 23, 1402 (2017).
doi:10.1038/nm.4458
Authors: Teresa Palomero & Adolfo Ferrando
In a recent study, Maciocia et al. develop a novel T cell receptor beta (TCRB) constant C1-chain-directed cellular immunotherapy for the treatment of T cell malignancies.
Source: Nature Medicine - Category: General Medicine Authors: Teresa Palomero Adolfo Ferrando Tags: News and Views Source Type: research